<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03122756</url>
  </required_header>
  <id_info>
    <org_study_id>IVD-SA-CS</org_study_id>
    <nct_id>NCT03122756</nct_id>
  </id_info>
  <brief_title>Effect of Intravenous Dexamethasone Before Spinal Anesthesia on Post-cesarean Section Pain</brief_title>
  <official_title>Effect of Intravenous Dexamethasone Before Spinal Anesthesia on Post-cesarean Section Pain: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      *Aim of the Work This study aims to assess the efficacy of intravenous injection of
      dexamethasone prior to spinal anesthesia in reducing post-cesarean section pain in women
      undergoing cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      *Research Hypothesis: In women undergoing cesarean section, intravenous injection of
      dexamethasone prior to spinal anesthesia may reduce post-cesarean section pain.

      *Research Question: In women undergoing cesarean section, does injecting intravenous
      dexamethasone prior to spinal anesthesia reduce post-cesarean section pain?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in post-cesarean pain</measure>
    <time_frame>2, 4, 8 and 12 hours after the procedure</time_frame>
    <description>post-cesarean pain degree scored by the patient on Visual Analogue Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sensory recovery</measure>
    <time_frame>2, 4, 8 and 12 hours after the procedure</time_frame>
    <description>sensory recovery time by cold object</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>motor recovery</measure>
    <time_frame>2, 4, 8 and 12 hours after the procedure</time_frame>
    <description>motor recovery time on Bromage scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nausea</measure>
    <time_frame>2, 4, 8 and 12 hours after the procedure</time_frame>
    <description>postoperative nausea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vomiting</measure>
    <time_frame>2, 4, 8 and 12 hours after the procedure</time_frame>
    <description>postoperative vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>shivering</measure>
    <time_frame>2, 4, 8 and 12 hours after the procedure</time_frame>
    <description>postoperative shivering</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Group (D)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will include 50 women who will receive intravenous dexamethasone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group (C)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>will include 50 women who will receive intravenous normal saline (0.9 %).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Intravenous injection of dexamethasone 0.1 mg/kg maximum 8 mg (diluted with distilled water to 2 mL) just prior to administration of spinal anesthesia.</description>
    <arm_group_label>Group (D)</arm_group_label>
    <other_name>Decadron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>Intravenous injection 2 mL intravenous normal saline (0.9 %) just prior to administration of spinal anesthesia.</description>
    <arm_group_label>Group (C)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

               -  A gestational age of 38 weeks or more and planned for elective cesarean section.

               -  Living fetus.

               -  Any number of previous cesarean section.

               -  Intact amniotic membranes.

               -  No history of bleeding tendency.

          -  Exclusion Criteria:

               -  Refuse to participate after counseling.

               -  Contraindication to spinal anesthesia (coagulopathy significant hypovolemia
                  systemic or local sepsis - increased intracranial pressure - local anesthetic or
                  fentanyl allergy).

               -  High risk pregnancies as pre-eclampsia, any medical disorder (diabetes mellitus,
                  cardiac disease or and thyroid disease).

               -  Contraindication to corticosteroids e.g. systemic fungal infection

               -  Steroid medication one week before the operation.

               -  Chronic pain or daily intake of analgesic.

               -  Abnormal placentation e.g. placenta previa.

               -  Intrauterine infection.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women who will be planned for elective cesarean section.</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud AA ElShourbagy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Obstetrics and Gynecology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dalia A Nasr, MD</last_name>
    <role>Study Director</role>
    <affiliation>Professor of Anesthesia, Intensive Care and Pain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bassem A Islam, MD</last_name>
    <role>Study Director</role>
    <affiliation>Lecturer in Obstetrics &amp; Gynecology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdelhameed AA Ismail, MBBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Resident of Obstetrics &amp; Gynecology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud AA ElShourbagy, MD</last_name>
    <phone>+201001448189</phone>
    <email>elshourbagym22@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ain Shams Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud AA ElShourbagy, MD</last_name>
      <phone>+201001448189</phone>
      <email>elshourbagym22@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2017</study_first_submitted>
  <study_first_submitted_qc>April 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Abdelhameed Ahmed Ali Ismail</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Intravenous Dexamethasone</keyword>
  <keyword>Spinal Anesthesia</keyword>
  <keyword>Post-cesarean Section Pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

